{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:35:06Z","timestamp":1790393706480,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To identify baseline characteristics that predict vision decline (VD) in patients with chronic central serous chorioretinopathy who have anatomically responded to half-dose photodynamic therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients with chronic central serous chorioretinopathy who underwent half-dose photodynamic therapy once and achieved subretinal fluid resolution were retrospectively reviewed. They were categorized into the VD group and the vision maintenance\/improvement group based on visual acuity 6 months posttreatment. Baseline OCT, OCT angiography, fundus autofluorescence, and choroidal vascular hyperpermeability patterns were analyzed to identify predictive factors for the VD group. Predictive models were evaluated using the area under the curve from receiver operating characteristic curves to estimate the likelihood of VD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 63 patients were reviewed, with 14 in VD group and 49 in vision maintenance\/improvement group. OCT measurements revealed that VD group had significantly thinner layers from internal limiting membrane (ILM) to external limiting membrane (IE) and from ILM to ellipsoid zone (IEZ) (IE: 79.3 \u00b1 22.2 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m vs. 100.1 \u00b1 20.1 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001; IEZ: 93.9 \u00b1 23.7 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m vs. 114.5 \u00b1 19.8 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002). The IE and IEZ cutoff values were 84 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m and 95.5 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.006 and 0.008), respectively. The predictive model's area under the curve was 0.743 for IE alone. The best model, which included IE, age, sex, spherical equivalent, fundus autofluorescence, and choroidal vascular hyperpermeability patterns, achieved an the area under the curve of 0.860.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Baseline IE and IEZ are significant predictors of VD in patients with chronic central serous chorioretinopathy after half-dose photodynamic therapy, making them useful for identifying high-risk patients and discussing these potential outcomes in advance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004412","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:09Z","timestamp":1738022409000},"page":"1210-1217","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["PREDICTIVE MODELS OF VISUAL DECLINE AFTER SUCCESSFUL HALF-DOSE PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY"],"prefix":"10.1097","volume":"45","author":[{"given":"Yu-Te","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Eye Center, China Medical University Hospital, Taichung, Taiwan;"},{"name":"Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Chung","family":"Chou","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhih-Yi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Eye Center, China Medical University Hospital, Taichung, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chuen","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, China Medical University, Taichung, Taiwan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou-Ting","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of General Medicine, China Medical University Hospital, Taichung, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Lan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Eye Center, China Medical University Hospital, Taichung, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-381X","authenticated-orcid":false,"given":"San-Ni","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Eye Center, China Medical University Hospital, Taichung, Taiwan;"},{"name":"School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/BF02169203","article-title":"New hypotheses on the pathogenesis and treatment of serous retinal detachment","volume":"226","author":"Marmor","year":"1988","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R3-20250527","first-page":"1","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63","author":"Gass","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2019","journal-title":"Eye (Lond)."},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1007\/s00417-023-06201-2","article-title":"Increased risk of glaucoma development in patients with central serous chorioretinopathy: results of a 11-year population-based cohort study","volume":"261","author":"Huang","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/IAE.0000000000001443","article-title":"Acute central serous chorioretinopathy: factors influencing episode duration","volume":"37","author":"Daruich","year":"2017","journal-title":"Retina"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","article-title":"Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage","volume":"115","author":"Chen","year":"2008","journal-title":"Ophthalmology"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00417-024-06373-5","article-title":"Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy","volume":"262","author":"Huang","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.survophthal.2023.03.001","article-title":"Comparing interventions for chronic central serous chorioretinopathy: a network meta-analysis","volume":"68","author":"You","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/aos.15263","article-title":"Comparative efficacy of treatments for chronic central serous chorioretinopathy: a systematic review with network meta-analyses","volume":"101","author":"van Dijk","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","article-title":"Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy","volume":"126","author":"Mrejen","year":"2019","journal-title":"Ophthalmology"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.020","article-title":"Half-dose photodynamic therapy versus Eplerenone in chronic central serous chorioretinopathy (SPECTRA): a randomized controlled trial","volume":"233","author":"van Rijssen","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajo.2023.05.022","article-title":"Characteristics related to visual acuity loss after successful photodynamic therapy for eyes with central serous chorioretinopathy","volume":"256","author":"Funatsu","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ajo.2015.03.005","article-title":"Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images","volume":"159","author":"Sonoda","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/IAE.0000000000002580","article-title":"Fundus autofluorescence patterns in central serous chorioretinopathy","volume":"40","author":"Han","year":"2020","journal-title":"Retina"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"e946","DOI":"10.1111\/aos.16679","article-title":"Choroidal hyperpermeability patterns correlate with disease severity in central serous chorioretinopathy: CERTAIN study report 2","volume":"102","author":"Pauleikhoff","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/ICB.0000000000000498","article-title":"Short-term findings on optical coherence tomography and microperimetry in chronic central serous chorioretinopathy patients treated with half-dose photodynamic therapy","volume":"12","author":"van Dijk","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/IAE.0000000000002040","article-title":"Chronic central serous chorioretinopathy: early and late morphological and functional changes after verteporfin photodynamic therapy","volume":"39","author":"Iacono","year":"2019","journal-title":"Retina"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.2147\/OPTH.S174573","article-title":"Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy","volume":"12","author":"Mohabati","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","article-title":"Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy","volume":"121","author":"Lim","year":"2014","journal-title":"Ophthalmology"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1167\/iovs.05-0838","article-title":"Ocular changes after photodynamic therapy","volume":"47","author":"Tzekov","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/IAE.0000000000003686","article-title":"Increasing evidence for the safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy","volume":"43","author":"Feenstra","year":"2023","journal-title":"Retina"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0161-6420(03)00452-4","article-title":"Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin","volume":"110","author":"Schmidt-Erfurth","year":"2003","journal-title":"Ophthalmology"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10384-008-0613-z","article-title":"Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy","volume":"53","author":"Lee","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41433-021-01762-0","article-title":"Threshold thickness of foveal outer nuclear layer associated with outcomes of photodynamic therapy in central serous chorioretinopathy","volume":"36","author":"Yu","year":"2022","journal-title":"Eye (Lond)."},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.62.3.25","article-title":"Choroidal and retinal changes after systemic adrenaline and photodynamic therapy in non-human primates","volume":"62","author":"Cheong","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/08820538.2017.1416414","article-title":"Half-fluence photodynamic therapy for chronic central serous chorioretinopathy: predisposing factors for visual acuity outcomes","volume":"33","author":"Matu\u0161kov\u00e1","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2023.04.016","article-title":"A photodynamic therapy index for central serous chorioretinopathy to predict visual prognosis using pretreatment factors","volume":"253","author":"Funatsu","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"104224","DOI":"10.1016\/j.pdpdt.2024.104224","article-title":"Clinical predictive factors and imaging biomarkers of treatment response to half dose PDT in patients with chronic central serous chorioretinopathy","volume":"48","author":"Mirshahi","year":"2024","journal-title":"Photodiagnosis Photodyn Ther"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004412","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:48:04Z","timestamp":1748357284000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004412","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}